Tirzepatide 20mg

Description

Tirzepatide 20mg is a research-grade synthetic
peptide available in Canada from Verified Peptides.

Tirzepatide is a dual GIP and GLP-1 receptor
agonist. Tirzepatide peptide Canada researchers
have shown significant interest in this compound
for its role in metabolic regulation, glucose
homeostasis, and obesity research.

This compound has been extensively studied in
relation to insulin secretion, glucose metabolism,
energy homeostasis, and adipose tissue regulation
in laboratory settings. As a dual agonist targeting
both GIP and GLP-1 receptors simultaneously, it
represents a highly specific research tool for
metabolic pathway studies.

Each vial contains 20mg of Tirzepatide with 99%+
purity, independently verified by Janoshik
third-party laboratory testing. Our Tirzepatide
is manufactured under strict quality control
standards and supplied exclusively for in-vitro
and laboratory research purposes.

Scientists continue to investigate its role in
various biological processes including GLP-1
receptor activation, GIP receptor signaling,
pancreatic function models, and metabolic
regulation in laboratory settings. Research
into Tirzepatide has expanded significantly
over the past few years.

Verified Peptides Canada is committed to supplying
the highest quality research peptides to the
scientific community across Canada. All orders
ship from Kingston, Ontario via Canada Post
with tracking provided.

Research Specifications:
– Purity: 99%+
– Format: Lyophilized powder
– Size: 20mg per vial
– Storage: Store at -20°C
– Type: Dual GIP/GLP-1 Receptor Agonist
– Shipping: Canada-wide via Canada Post

Scientific literature on Tirzepatide is available
at PubMed for researchers interested in its
mechanisms and biological activity.

Also available from Verified Peptides Canada:
Retatrutide for triple receptor research,
Semaglutide for GLP-1 receptor research, and
HGH Fragment 176-191 for metabolic research.

For research use only. Not for human consumption.
Shipped from Kingston, Ontario, Canada.